Abstract

OBJECTIVES

To investigate the occurrence and identify the factors contributing to hospitalization among individuals diagnosed with COVID-19.

METHODS

From June 15, 2020 to September 30, 2020, a cross-sectional study utilizing an online questionnaire was carried out in Jordan. The study included 657 COVID-19 patients who had recovered and had reached a minimum of 3 months post-illness. Sociodemographic and COVID-19-related data were collected. The questionnaire was distributed to members of the "My Experience with COVID-19 Association" in Jordan.

RESULTS

The prevalence of hospitalization among COVID-19 patients was 3%. Patients with hypertension (=0.00), diabetes mellitus (=0.00), and heart disease (=0.009); using angiotensin-converting enzyme inhibitors (ACE) and angiotensin-receptor blockers (ARBs) (=0.00); with body mass indexes (BMI) above normal (=0.005); and aged over 45 years (=0.00) were at higher risk of hospitalization. Using an odds ratio (OR), hypertension (OR=7.1), diabetes mellitus (OR=11.4), heart disease (OR=6.3), angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers use (OR=10.8), and having a BMI >25 (OR=5) were significant hospitalization risk factors. The seasonal influenza vaccine, smoking, and neuropsychological symptoms showed no significance.

CONCLUSION

Identifying high-risk groups can help them monitor their health and take preventive measures against COVID-19 infection.

MeSH

Infections, Angiotensin-Converting Enzyme Inhibitors, Comorbidity, Hypertension, Angiotensins, Pharmaceutical Preparations, Risk Factors, Hospitalization, Heart Diseases, Diabetes Mellitus, Covid-19